The frequency of symptomatic haemochromatosis in the general population and the potential efficacy of population screening is uncertain. Data from family members of clinically diagnosed index cases were used to estimate the frequency of the haemochromatosis genotype, the proportion of homozygous individuals with clinical manifestations, and the efficacy of transferrin saturation and serum ferritin measurements as screening tests.
Setting—
English language studies from Europe, North America, and Australia.
Methods—
Haemochromatosis zygosity was classified only by HLA haplotyping, the most reliable available method. All subsequent analyses were based on family members classified in this way.
Results—
An estimated 53 individuals per 10 000 are homozygous for haemochromatosis. Overall, 67% of male and 41% of female family members display at least one clinical manifestation; for men, the frequency increases with age. Transferrin saturation levels are 70% or above in an estimated 72% of homozygous men, along with three per 1000 heterozygous or unaffected men. Transferrin saturation levels are 60% or above in an estimated 67% of homozygous women, along with six per 1000 heterozygous or unaffected women. Serum ferritin levels, but not transferrin saturation levels, are associated with clinical manifestations.
Conclusions—
This information can be used to compare expected versus actual screening performance for intervention trials aimed at detecting haemochromatosis in the general population.
EdwardsCQKushnerJP.Screening for hemochromatosis. N Engl J Med, 1993;328:1616–20.
2.
BalanVBaldusWFairbanksVMichelsVBurrittMKleeG. Screening for hemochromatosis: A cost-effectiveness study based on 12,258 patients. Gastroenterology, 1994;107:453–9.
3.
PhatakPDGuzmanGWollJERobesonAPhelpsCE.Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med, 1994;154:769–76.
4.
HaddowJELedueTB.Preventing manifestations of hereditary haemochromatosis through population based screening. J Med Screen, 1994;1:16–21.
5.
KushnerJP.Screening for hemochromatosis (editorial). Gastroenterology, 1995;109:315–16.
6.
FederJNGnirkeAThomasWA novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 1996;13:399–408.
7.
BothwellTHCharltonRWMotulskyAG. Hemochromatosis. In: ScriverLRBeaudetALSlyWSValleD. eds. The metabolic and molecular basis of inherited disease, 7th ed.New York: McGraw-Hill, 1995:2237–70.
8.
BassettMLHallidayJWPowellLW.HLA typing in idiopathic hemochromatosis: Distinction between homozygotes and heterozygotes with biochemical expression. Hepatology, 1981;1:120–6.
9.
DadoneMMKushnerJPEdwardsCQBishopDTSkolnickMH.Hereditary hemochromatosis: Analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol, 1982;78:196–207.
10.
BorweinSTGhentCNFlanaganPRChamberlainMJValbergLS.Genetic and phenotypic expression of hemochromatosis in Canadians. Clin Invest Med, 1983;6:171–9.
11.
MilmanN. Iron status markers in hereditary hemochromatosis: Distinction between individuals being homozygous and heterozygous for the haemochromatosis alleles. Eur J Haematol, 1991;47:292–8.
12.
AdamsPC.Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: An analysis of 255 heterozygotes. Am J Hematol, 1994;45:146–9.
MohlerDNWhebyMS.Hemochromatosis heterozygotes may have significant iron overload when they also have hereditary spherocytosis. Am J Med Sci, 1986;86:645–9.
15.
EdwardsCQSkolnickMHKushnerJP.Coincidental nontransfusional iron overload and thalassemia minor: Association with HLA-linked hemochromatosis. Blood, 1981;58:844–8.
16.
EdwardsCQGriffenLMGoldgarDESkolnickMHKushnerJP.HLA-linked hemochromatosis alleles in sporadic porphyria cutanea. Gastroenterology, 1989;97:972–81.
17.
BassettMLDoranJJHallidayJWBashirHVPowellLW.Idiopathic hemochromatosis: Demonstration of homozygous-heterozygous mating by HLA typing of families. Hum Genet, 1982;60:352–6.
18.
CartwrightGEEdwardsCQKravitzKHereditary hemochromatosis. Phenotypic expression of the disease. N Engl J Med, 1979;301:175–9.
19.
SimonMFauchetRHespelJPIdiopathic hemochromatosis: A study of biochemical expression in 247 heterozygous members of 63 families: Evidence for a single major HLA-linked gene. Gastroenterology, 1980;78:703–8.
20.
LoweHJBarnettGO.Understanding and using the medical subject headings (MeSH) vocabulary to perform literature searches. JAMA, 1994;14:97–103.
Hereditary Hemochromatosis Practice Guidelines Development Task Force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta, 1996;245: 139–200.
23.
EdwardsCQ. Hemochromatosis and other iron storage disorders. In: LeeGRBithellTCFoersterJAthensJWLukensJN eds. Clinical Hematology, 9th ed.Philadelphia: Lea & Febiger, 1993:872–974.
24.
De BraekeleerM. A prevalence and fertility study of hæsmochromatosis in Saguenay-Lac Saint Jean. Ann Hum Biol, 1993;20:501–5.
25.
PortoGVincenteCFragaJDaSilvaBMDeSousaM. Importance of establishing appropriate local reference values for the screening of hemochromatosis: A study of three different control populations and 136 hemochromatosis family members. J Lab Clin Med, 1992;119:295–305.
26.
BeaumontCSimonMFauchetRSerum ferritin as a possible marker of the hemochromatosis allele. N Engl J Med, 1979;301:169–74.
27.
BoreckiIBRaoDCYaouanqJLalouelJM.Serum ferritin as a marker of affection for genetic hemochromatosis. Hum Hered, 1990;40:159–66.
28.
BerlinJALairdNMSacksHSChalmersTC.A comparison of statistical methods for combining event rates from clinical trials. Stat Med, 1989;8:141–51.
29.
AdamsPCKerteszAEValbergLS.Clinical presentation of hemochromatosis: A changing scene. Am J Med, 1991;90:445–9.
30.
MilmanNFengerKGraudalNANielsenLS.Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary hemochromatosis. Dan Med Bull, 1994;41:366–70.
31.
OlssonKSRitterBRosenUHeedmanPAStangardF. Prevalence of iron overload in central Sweden. Acta Med Scand, 1983;213:145–50.
32.
MuirWAMcLarenGDBraunWAskariA. Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families. Am J Med, 1984;76:806–14.
33.
ValbergLSLloydDAGhentCNClinical and biochemical expression of the genetic abnormalities in idiopathic hemochromatosis. Gastroenterology1980; 79:884–92.
34.
PowellLWSummersKMBoardPGAxelsenEWebbSHallidayJW.Expression of hemochromatosis in homozygous subjects: Implications for early diagnosis and prevention. Gastroenterology, 1990;98:1625–32.
35.
AdamsPC.Intrafamilial variation in hereditary hemochromatosis. Dig Dis Sci, 1992;37:361–3.
36.
EdwardsCQCarrollMBrayPCartwrightGE.Hereditary hemochromatosis: Diagnosis in siblings and children. N Engl J Med, 1977;297:7–13.
37.
KravitzKSkolnickMCanningsCGenetic linkage between hereditary hemochromatosis and HLA. Am J Hum Genet, 1979;31:601–19.
38.
BoreckiIBRaoDCYaouanqJLalouelJM.Percent transferrin saturation in segregating hemochromatosis. Am J Med Genet, 1990;36:301–5.
39.
BoreckiIBRaoDCLeMignonLYaouanqJSimonMLalouelJM.Genetic hemochromatosis: Distribution analysis of six laboratory measures of iron metabolism. Am J Med Genet, 1989;34:435–41.
40.
DixonWJ ed. BMDP statistical manual., Berkeley: University Press of California, 1992.
41.
LeggettBABrownNNBryantSJDuplockLPowellLWHallidayJW.Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Clin Chem, 1990;36:1350–5.
42.
LalouelJJordeL. Idiopathic hemochromatosis: Significance and implications of linkage to HLA. Ann NY Acad Sci, 1988;526:34–46.
43.
BradleyLAHaddowJEPalomakiGE.Population screening for haemochromatosis: A unifying analysis of published intervention trials. J Med Screen, 1996;3:178–84.
